Mayte Murillo, BS

Clinical Research Coordinator
University of Kentucky
Lexington, Kentucky, United States

Presentation(s):

• PPS56. A Phase II Trial Evaluating Combination Cabozantinib and Pembrolizumab in Treatment Refractory Metastatic Pancreatic Adenocarcinoma

  Friday, March 6, 2026
  3:40 PM - 4:10 PM MST